Editor: Daniel J. Carlat, M.D., is Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine and maintains a private practice in Newburyport, Massachusetts. He graduated from the psychiatric residency at Massachusetts General Hospital in 1995, has written a small textbook called The Psychiatric Interview, and is founding editor of The Practical Guide Series in Psychiatry, published by Lippincott Williams & Wilkins.

Associate Editor: Marcia L. Zuckerman, M.D., practices psychopharmacology at the Cambridge Health Alliance, Cambridge, Massachusetts.

Editorial Board: Marc E. Agronin, M.D., Director of Mental Health Services, Miami Jewish Home & Hospital for the Aged; Assistant Professor of Psychiatry, University of Miami School of
Medicine, Miami, Florida.

Richard Gardiner, M.D., Psychiatrist in private practice in Ukiah, California.

Ivan Goldberg, M.D., Creator, Depression Central Website, psychopharmacologist in private practice, New York City.

Alan D. Lyman, M.D., Child and adolescent psychiatrist in private practice, New York City.

Robert L. Mick, M.D., Medical Director of DePaul Addiction Services, Rochester, New York.

Michael Posternak, M.D., Assistant Clinical Professor of Psychiatry, Brown University School of Medicine.

Dr. Carlat, with editorial assistance from Dr. Zuckerman, is the author (unless other authorship is specified) of all articles and interviews for The Carlat Psychiatry Report. All editorial content
is reviewed by the editorial board. Dr. Carlat and Dr. Zuckerman have disclosed that they have no significant relationships with or financial interests in any commercial companies pertaining to
this educational activity. Dr. Agronin has disclosed that he was or is the recipient of research grants from Forest Laboratories, Memory Pharmaceuticals, Novartis, Ono Pharmaceuticals,
Progenics, Solvay, and Theravance and was or is a member of the speakers bureaus of AstraZeneca, Forest Laboratories, and Janssen Pharmaceutica. Dr. Gardiner is a member of the speakers
bureaus of Forest Laboratories, Wyeth Pharmaceuticals, and GlaxoSmithKline. Dr. Goldberg, Dr. Lyman, Dr. Mick, and Dr. Posternak have disclosed that they have no significant relationships
with or financial interests in any commercial companies pertaining to this educational activity. Wolters Kluwer Health has identified and resolved all faculty conflicts of interest
regarding this educational activity.